Category: Longevity & Regenerative Research | Reading time: 6 min | For research use only
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973 by biochemist Loren Pickart. It is found in human plasma, saliva, and urine, with concentrations highest in youth and declining significantly with age — a pattern that has motivated decades of research into its role in tissue maintenance, wound healing, and cellular regulation.
GHK-Cu has emerged as one of the most extensively researched peptides in regenerative biology, with published studies documenting interactions with over 4,000 human genes. This broad regulatory footprint distinguishes it from most research peptides and has made it a compound of sustained scientific interest across dermatological, wound healing, and anti-aging research domains.
This article summarizes published research on GHK-Cu for scientific and educational purposes. All compounds discussed are strictly for laboratory and research use only.
Molecular Profile
- Full name: Glycyl-L-histidyl-L-lysine : copper (2+) complex
- Abbreviation: GHK-Cu
- Molecular weight: 340.38 g/mol (GHK tripeptide); 403.9 g/mol (copper complex)
- CAS Number: 89030-95-5
- Structure: Tripeptide (Gly-His-Lys) with copper (II) ion coordinated through histidine imidazole and terminal amine groups
- Form: Lyophilized powder (research grade)
- Stability: Store at −20°C; protect from light; the copper complex is more stable than free GHK
- Solubility: Soluble in water; the copper complex improves aqueous stability relative to free peptide
The copper ion is integral to GHK-Cu's biological activity — it is not simply a delivery vehicle. The Cu²⁺ coordination geometry in the GHK complex determines its interaction with specific receptors and enzyme systems, and studies using copper-free GHK (the free tripeptide alone) show reduced activity in several assay systems.
Discovery and Plasma Concentrations
Loren Pickart identified GHK in 1973 while investigating factors in human plasma that stimulated liver tissue restoration. The peptide's copper-binding properties were characterized in subsequent work, and the combined GHK-Cu complex became the subject of biological investigation from the late 1970s onward.
Published plasma concentration data in humans:
| Age group | Approximate plasma GHK concentration |
|---|---|
| 20–25 years | ~200 ng/mL |
| 60–70 years | ~80 ng/mL |
| 80+ years | ~40–60 ng/mL |
This age-dependent decline parallels changes in skin thickness, wound healing capacity, and tissue repair efficiency — an association that has generated hypotheses about GHK-Cu's role in age-related tissue changes, and motivated research using exogenous GHK-Cu in aged animal and cell culture models.
Mechanisms Studied in Preclinical Research
Gene expression regulation The most striking finding in GHK-Cu research is its documented effect on gene expression at scale. Research published by Pickart and Margolina (2018) using genome-wide analysis identified GHK-Cu's association with modulation of over 4,000 human genes — including upregulation of genes associated with tissue remodeling, antioxidant defense, and nervous system maintenance, and downregulation of genes associated with inflammatory pathways and cancer-related processes. This broad regulatory footprint is unusual for a tripeptide and has positioned GHK-Cu as a compound of interest in systems biology research.
Collagen and extracellular matrix synthesis Multiple in vitro studies have examined GHK-Cu's effect on fibroblast activity, reporting associations with increased production of collagen types I and III, elastin, and glycosaminoglycans in treated cell cultures. These findings have been replicated across research groups and represent one of the most consistent findings in the GHK-Cu literature.
Wound healing models In vivo wound healing models in rodents have examined GHK-Cu's effect on wound contraction rates, re-epithelialization, and collagen deposition. Publications have reported accelerated wound closure and improved tensile strength in treated wounds compared to controls, with histological analysis showing differences in granulation tissue organization.
Antioxidant activity Research has documented GHK-Cu's association with upregulation of antioxidant enzyme systems including superoxide dismutase (SOD) and catalase. Studies have also examined its role in copper transport to ceruloplasmin — a key plasma antioxidant enzyme — suggesting a role in systemic copper metabolism beyond local tissue effects.
Nerve tissue research Published studies have examined GHK-Cu in neural models, reporting associations with nerve outgrowth promotion in cell culture systems and neuroprotective effects in oxidative stress models. Research has documented interactions with neurotrophic factor expression, including BDNF (brain-derived neurotrophic factor) in treated neural cell cultures.
Anti-inflammatory signaling Research has examined GHK-Cu's interaction with NF-κB signaling pathways — the master regulator of inflammatory gene expression. Studies have reported downregulation of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β in treated cell and animal models, an effect researchers have proposed may relate to GHK-Cu's copper-mediated interaction with oxidative stress pathways.
Hair follicle research In vitro and in vivo models examining hair follicle biology have investigated GHK-Cu's effect on hair follicle size, proliferative activity of follicular keratinocytes, and expression of hair growth-associated genes. This has been an area of growing research interest, with publications appearing in dermatological and trichological journals.
Areas of Active Research
Dermatological applications Skin aging models have used GHK-Cu to investigate extracellular matrix remodeling, epidermal thickness maintenance, and UV damage response in keratinocyte cultures. The compound appears in both injectable research formats and topical formulations examined for transdermal penetration and local tissue distribution.
Oncological research The gene expression data showing GHK-Cu's association with downregulation of oncogene pathways has prompted research in cancer biology. Studies have examined its effect on tumor cell proliferation, metastasis-associated gene expression, and tumor microenvironment markers in cell line models. This represents a more speculative but active area of investigation.
Chronic wound models Research using diabetic animal wound models — which exhibit impaired healing — has examined whether GHK-Cu supplementation restores healing parameters toward non-diabetic baselines. This application context has clinical research relevance given the prevalence of chronic wound complications in diabetic populations.
Lung tissue research Published studies have examined GHK-Cu in models related to chronic obstructive pulmonary disease (COPD) and lung tissue remodeling, with researchers investigating its interaction with genes associated with tissue repair in pulmonary fibroblast cultures.
Key Published Research
- Pickart L & Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987.
- Pickart L, et al. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.BioMed Research International, 2015, 648108.
- Gorouhi F & Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345.
- Kang YA, et al. (2009). Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Archives of Dermatological Research, 301(4), 301–306.
- Campbell JD, et al. (2012). GHK peptide inhibits bleomycin-induced pulmonary fibrosis in mice. Journal of Translational Medicine, 10, 212.
GHK-Cu vs GHK: Research Distinction
Researchers should note the distinction between GHK (the free tripeptide) and GHK-Cu (the copper complex). While both appear in the literature, the copper-complexed form demonstrates greater biological activity in most assay systems, and the majority of significant findings — particularly the gene regulation data — relate specifically to the copper complex. Studies using GHK without copper supplementation may show attenuated effects and should be evaluated separately from GHK-Cu literature.
When sourcing for research, confirm that the supplied compound is the copper complex (GHK-Cu) rather than the free tripeptide, and verify the copper content in the COA documentation.
Storage and Handling Notes
GHK-Cu is generally more stable than many larger research peptides due to its small size and the stabilizing effect of copper coordination. However, standard peptide handling protocols apply:
- Store lyophilized powder at −20°C
- Protect from light — copper complexes can be photosensitive
- Reconstitute in sterile water; aqueous solutions are stable for 3–5 days at +4°C
- Avoid alkaline pH extremes which can disrupt copper coordination geometry
- Aliquot reconstituted solution for single use; avoid freeze-thaw cycling
NordBioLab supplies GHK-Cu as a research-grade lyophilized copper peptide complex with ≥98% purity (HPLC verified) and full COA documentation per batch.
All products and information provided by NordBioLab are strictly for scientific research and laboratory use only. Not for human or veterinary consumption. This article does not constitute medical advice.